These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35850073)

  • 1. Adverse event classification and signal detection of data from the customer service and pharmacovigilance of a multinational veterinary pharmaceutical company.
    Marcon DS; Queiroz MR; Baquero OS
    Prev Vet Med; 2022 Sep; 206():105704. PubMed ID: 35850073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
    Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
    Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.
    Lee I; Lee TA; Crawford SY; Kilpatrick RD; Calip GS; Jokinen JD
    Expert Opin Drug Saf; 2020 Oct; 19(10):1357-1366. PubMed ID: 32662668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.
    Ang PS; Chen Z; Chan CL; Tai BC
    Expert Opin Drug Saf; 2016 May; 15(5):583-90. PubMed ID: 26996192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
    Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
    Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary pharmacovigilance in India: A need of hour.
    Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
    Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system.
    Shu Y; Ding Y; Dai B; Zhang Q
    Expert Opin Drug Saf; 2022 Apr; 21(4):563-572. PubMed ID: 34918584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
    Trippe ZA; Brendani B; Meier C; Lewis D
    Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.
    Lee I; Jokinen JD; Crawford SY; Calip GS; Kilpatrick RD; Lee TA
    Ther Innov Regul Sci; 2021 Jan; 55(1):142-151. PubMed ID: 32720297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual review of pharmacovigilance.
    Diesel G; Cooles S
    Vet Rec; 2018 Jul; 183(2):72. PubMed ID: 30002183
    [No Abstract]   [Full Text] [Related]  

  • 12. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.
    Ahmed I; Thiessard F; Miremont-Salamé G; Haramburu F; Kreft-Jais C; Bégaud B; Tubert-Bitter P
    Drug Saf; 2012 Jun; 35(6):495-506. PubMed ID: 22612853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2017].
    Müntener C; Kupper J; Naegeli H; Gassner B
    Schweiz Arch Tierheilkd; 2019 Feb; 161(2):107-112. PubMed ID: 30696613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2016].
    Müntener CR; Müntener C; Kupper J; Naegeli H; Gassner B
    Schweiz Arch Tierheilkd; 2017 Nov; 159(11):581-585. PubMed ID: 29128859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
    Vickers-Smith R; Sun J; Charnigo RJ; Lofwall MR; Walsh SL; Havens JR
    Drug Alcohol Depend; 2020 Jan; 206():107709. PubMed ID: 31732295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
    Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N
    PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.